4.4 Article

Muscle ultrasound is a sensitive biomarker in oculopharyngeal muscular dystrophy

期刊

MUSCLE & NERVE
卷 66, 期 4, 页码 453-461

出版社

WILEY
DOI: 10.1002/mus.27679

关键词

biomarker; clinical measures; muscle ultrasound; oculopharyngeal muscular dystrophy; orofacial and limb muscles

资金

  1. AFM Telethon [17110]

向作者/读者索取更多资源

This study aimed to investigate the application of QMUS in OPMD. The results showed that QMUS can detect muscle pathology and can be used as a longitudinal imaging biomarker in OPMD. AEI and muscle thickness were significantly correlated with clinical data. Deterioration in AEI and decreased muscle thickness were observed over time.
Introduction/Aims Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, progressive muscle disease. Quantitative muscle ultrasound (QMUS) assesses structural changes in muscles and is a sensitive biomarker in neuromuscular disorders. Our aim of this study was to determine whether QMUS can detect muscle pathology and can be used as longitudinal imaging biomarker in OPMD. Methods Genetically confirmed OPMD patients, recruited by their treating physicians or from the national neuromuscular database, were examined twice, 20 months apart, using QMUS of orofacial and limb muscles, and measurements of functional capacity and muscle strength. Absolute echo intensity (AEI) and muscle thickness of all muscles were analyzed and correlated with clinical data. Results The tongue, deltoid, iliopsoas, rectus femoris, and soleus muscles showed increased AEI at baseline compared with normal values in 43 OPMD patients, with the rectus femoris being most often affected (51%).The AEI and muscle thickness of 9 of 11 muscles correlated significantly with the motor function measure, 10-step stair test, swallowing capacity, dynamometry, Medical Research Council grade, tongue strength, and bite force (r = 0.302 to -0.711). Between baseline and follow-up, deterioration in AEI was found for the temporalis, tongue, and deltoid muscles, and decreased muscle thickness was detected for the temporalis, masseter, digastric, tongue, deltoid, iliopsoas, and soleus muscles (P < .05). No relation was found between the change in AEI and repeat length or disease duration. Discussion QMUS detected muscle pathology and disease progression in OPMD over 20 months. We conclude that QMUS should be considered as a biomarker in treatment trials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据